SEC Tracker
Get the app

Alset Capital Acquisition ESYN

Alset Capital Acquisition Q3 FY23: net loss $176K

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Alset Capital Acquisition reported for Q3 FY23, the quarter ended Aug 31, 2023, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Net income−$176KNo year-earlier figure tagged10-Q income statement, on EDGAR
  2. Cash and cash equivalents$812KNo year-earlier figure tagged10-Q balance sheet, on EDGAR
  3. Cash from operations−$474KNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Alset Capital Acquisition files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 5122 and related industry codes: the same peer list as the financial tables.

  1. Stemtech STEK public float $6M, Jun 30, 2025
  2. Cosmos Health COSM public float $10M, Jun 30, 2025
  3. DataMeds AI MEDS public float $27M, Jun 30, 2025
  4. Sharing Services Global SHRG
  5. Nu Skin Enterprises NUS public float $390M, Jun 30, 2025